Medication Affordability and Patent Integrity Act

Hozzl · 2024-03-13T17:18:05Z

Explore the details of Senate Bill 2780 Medication Affordability and Patent Integrity Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Commerce. Stay informed on legislative developments.

3/13/2024, 5:18 PM

Summary of Bill S 2780

Bill 118 s 2780, also known as the Medication Affordability and Patent Integrity Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the rising costs of prescription medications and to ensure that patents are not being abused to prevent competition and keep prices high.

One key provision of the bill is the establishment of a Prescription Drug Affordability Board, which would be responsible for setting limits on the prices of certain medications. This board would take into account factors such as the cost of production, the value of the medication to patients, and the prices of similar medications in other countries.

Another important aspect of the bill is the strengthening of patent laws to prevent pharmaceutical companies from extending their patents beyond what is necessary to recoup their research and development costs. This would help to promote competition in the pharmaceutical industry and lower prices for consumers. Overall, the Medication Affordability and Patent Integrity Act aims to make prescription medications more affordable for all Americans by addressing the root causes of high drug prices. It is currently being debated in Congress, and its passage could have a significant impact on the healthcare system in the United States.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2780

Bill S 2780 is currently in the status of Bill Introduced since September 13, 2023. Bill S 2780 was introduced during Congress 118 and was introduced to the Senate on September 13, 2023. Bill S 2780's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 13, 2023

Bipartisan Support of Bill S 2780

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2780

Primary Policy Focus

Commerce

Alternate Title(s) of Bill S 2780

Medication Affordability and Patent Integrity Act

A bill to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.